Ethos Financial Group »

Fibrobiologics shares owned by Ethos Financial Group

Quarter-by-quarter ownership of Fibrobiologics (FBLG) shares owned by Ethos Financial Group from 13F filings

Historical chart of Ethos Financial Group investment in Fibrobiologics

Tip: Access up to 7 years of quarterly data

All positions including Fibrobiologics held by Ethos Financial Group consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Fibrobiologics by Ethos Financial Group

Quarter filed Position value Share count Share price at filing
2024-06-30 $127k 26k 4.99

More positions owned by Ethos Financial Group

Schwab US Broad Market ETF Etf (SCHB)
Alpha Architect 1-3 Month Box ETF Etf (BOXX)
Schwab US Large Cap ETF Etf (SCHX)
Vanguard Total World Stock ETF Etf (VT)
Schwab US Large Cap Growth ETF Etf (SCHG)
Vaneck Morningstar Wide Moat ETF Etf (MOAT)
Abrdn Physical Gold Shares ETF Etf (SGOL)
iShares TIPS Bond ETF Etf (TIP)
Schwab US Large Cap Value ETF Etf (SCHV)
Spdr S&p 500 Etf Etf (SPY)
iShares 0-5 Year TIPS Bond ETF Etf (STIP)
Invsc QQQ Trust SRS 1 ETF Etf (QQQ)
Apple (AAPL)
iShares Short Treasury Bond ETF Etf (SHV)
Wisdomtree Managed Futures Strat ETF Etf (WTMF)

View all positions for Ethos Financial Group

Top funds holding Fibrobiologics

BlackRock
State Street Corporation
Geode Capital Management
Cascade Financial Partners
Vanguard Group
Requisite Capital Management
American Institute for Advanced Investment Management
Bank of America Corporation
Bank of New York Mellon
Charles Schwab Investment Management
RMR Wealth Builders
Concurrent Investment Advisors
Nuveen Asset Management
ERn Financial
Ethos Financial Group

View all funds holding Fibrobiologics